The social-networking giant defies law of large numbers, showing benefits of scale.
Amgen Inc. said its second-quarter earnings rose 13% on better-than-expected revenue growth, which was again driven by sales of key drugs such as Enbrel.
Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC’s generics business, conditioned upon Teva’s divestiture of 75 drugs to rivals.
A Florida appeals court temporarily lifted the threat of personal bankruptcy hanging over Gawker Media founder Nick Denton as a result of a heated legal battle with former wrestler Hulk Hogan.
Demand for long-lasting factory goods fell sharply in June, a sign overseas turmoil is weighing on U.S. manufacturers.
Federal investigators are seeking information about government-billing practices at Alere, adding to a litany of woes at the diagnostic-testing company, as it seeks to complete a deal to sell itself.
Facebook once again reported growing profit on the strength of its mobile-advertising business, sending its shares higher in after-hours trading.
Alphabet shares appear to be underappreciated ahead of second-quarter earnings.
Google and Facebook could learn the importance of focus from Yahoo, AOL and their ilk: Don’t try to be everything to everyone by copying, buying or mimicking the latest rival for users’ attention.
The Federal Reserve’s caution on rates could fade quicker than investors think.